Emergent BioSolutions EBS 深 沪
等待开盘 12-15 09:30:00 美东时间
11.41
-0.310
-2.65%
华盛通- 最 高11.85
- 今 开11.77
- 成交量 56.82万股
- 最 低 11.34
- 昨 收 11.72
- 总市值 6.09亿
- 52周最高 13.4099
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.02
- 委 比 81.82%
- 总股本 5335.11万
- 历史最高 137.61
- 量 比 0.64
- 振 幅 4.35%
- 历史最低 1.42
- 每 手 1
- 风险率 2.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
Emergent BioSolutions announced that the U.S. FDA has approved its supplemental Biologics License Application (sBLA) for its Winnipeg, Canada facility to manufacture and test raxibacumab, a monoclonal antibody for treating and preventing inhalational anthrax. The approval supports the company's multi-year transformation strategy to streamline its manufacturing network. The Winnipeg facility, with over 45 years of experience, now adds production c...
12-12 13:30
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
<p>Emergent BioSolutions celebrates the 10-year anniversary of the FDA approval of NARCAN® (naloxone HCl) Nasal Spray, the first FDA-approved nasal naloxone spray for opioid overdose treatment. Over 85 million doses have been distributed, saving countless lives. In 2023, NARCAN® became the first OTC naloxone product, increasing accessibility. Efforts include training first responders, expanding distribution, and advocating for legal protections. ...
11-18 13:00
美股牛股 | CMBM涨超27%！与星链携手推出全新集成网络方案；医疗股GH绩后大涨近28%
CMBM涨超27%！与星链携手推出全新集成网络方案；Q3收入同比增长39%超预期，医疗股GH绩后大涨近28%；MTSR涨超22%，拟获诺和诺德要约收购>>
10-31 14:55
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Oracle 零日漏洞蔓延：数十家企业数据或被窃——企业级数据泄露防线如何重建？
据安全情报机构报告，今年 10 月，一起针对 Oracle E-Business Suite 的零日漏洞攻击已造成多家企业核心数据被窃。 此类漏洞虽起源于中间...
10-29 17:16
全球化新篇章！华大智造与Swiss Rockets达成CoolMPS测序技术授权...
10月28日，经2025年第四次临时股东大会审议通过，华大智造将通过美国子公司MGI US LLC及Complete Genomics,Inc.，与瑞士生物科技...
10-28 19:30
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
A recent survey of U.S. policy opinion leaders highlights growing concerns over biological attacks, with 65% believing the likelihood of such an attack is rising, compared to 60% for nuclear threats. Nearly half (45%)认为美国对生物攻击准备不足。专家指出，生物攻击的相对低成本和易实施性使其比核武器更具威胁。此外，调查显示生物威胁被视为优先的国家安全问题，超过核威胁。超过70%的受访者认为生物攻击比核攻击更容易实施，接近一半认为生物攻击更可能发生。调查还强调了国际 treaties如CWC和BTWC的限制，以及非传统生物剂如芬太尼带来的持续挑战。
10-28 12:00
S&P Global and CME Group Complete Sale of OSTTRA to KKR
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- S&P Global (NYSE: SPGI) and CME Group today announced that they have completed the sale of OSTTRA to KKR, a leading global investment firm. The terms ...
10-10 19:00
Oracle rises even as Google says e-business cybersecurity incident is widespread
Oracle (NYSE:ORCL) rose than 2% on Thursday, even as Google's (NASDAQ:GOOG) (NASDAQ:GOOG) Mandiant cybersecurity unit said the cybersecurity incident into Oracle's e-business unit is widespread. “Our ...
10-09 23:10
CME Group Announces That Its Cryptocurrency Futures And Options Will Be Available To Trade 24 Hours A Day, Seven Days A Week Beginning In Early 2026, Pending Regulatory Review
CHICAGO, Oct. 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its cryptocurrency futures and options will be available to trade 24 hours a day, seven days a week
10-02 22:07
